Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials

BACKGROUND: Cardiac magnetic resonance (CMR) T1 mapping has been used to characterize myocardial diffuse fibrosis. The aim of this study is to determine the reproducibility and sample size of CMR fibrosis measurements that would be applicable in clinical trials. METHODS: A modified Look-Locker with...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Songtao, Han, Jing, Nacif, Marcelo S, Jones, Jacquin, Kawel, Nadine, Kellman, Peter, Sibley, Christopher T, Bluemke, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552738/
https://www.ncbi.nlm.nih.gov/pubmed/23272704
http://dx.doi.org/10.1186/1532-429X-14-90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552738/
https://www.ncbi.nlm.nih.gov/pubmed/23272704
http://dx.doi.org/10.1186/1532-429X-14-90

Ejemplares similares